# reverie (blogs) — RSS Amplifier

Recent posts from the 1 feeds in the RSS Amplifier directory that cover reverie.

Page: <https://rssamplifier.com/topics/reverie/blogs>  
Feed: <https://rssamplifier.com/topics/reverie/blogs.md>

---

## [AI for Bio has a Fuzzy API problem](https://ankitg.me/blog/2026/05/04/fuzzy_api.html)

_2026-05-04 · Ankit Gupta_

“AI for bio” is getting hot again. Given the excitement in the current moment, I thought I’d share a bit about what actually makes biology uniquely hard as an application domain for machine learning. The reason is not simply that biology is complicated, though it obviously is. ML is good at many things that are complicated. The deeper reason is that drug discovery does not have the kind of clean…

## [Startups start with a minimum evolvable product](https://ankitg.me/blog/2025/11/10/minimum-evolvable-product.html)

_2025-11-10 · Ankit Gupta_

Early users are a strange bunch. Here is a worthwhile thought experiment: how many products do you use that you were one of the first 10 users of? I would bet that for nearly everyone that number is 0. Most people are not early adopters. There is nearly nothing any startup founder could say that could lead them to be their first customer, and especially not a paying customer. There are other…

## [Making a Default-alive Techbio Company](https://ankitg.me/blog/2025/08/27/making-a-default-alive-techbio-company.html)

_2025-08-27 · Ankit Gupta_

Most biotech startups are default dead. In fact, most of them earn zero revenue throughout their entire existence, regardless of how many millions of dollars they raise. This is usually true even after they IPO – most are still many years from being able to sell their therapeutics on the market. For software companies, being default alive vs default dead has a simple definition as articulated by…

## [Some Thoughts on Medical Superintelligence](https://ankitg.me/blog/2025/07/01/medical-superintelligence.html)

_2025-07-01 · Ankit Gupta_

Microsoft AI released a report this week about MAI-DxO , their research on an LLM orchestration system for medical diagnosis, and an accompanying blog titled The Path to Medical Superintelligence . To me, this is one of the most exciting application domains of AI. Here are some thoughts on Microsoft’s approach. These are a mix of my own opinions and reactions from some friends who are doctors. The…

## [On the Eve of Superintelligence](https://ankitg.me/blog/2025/01/27/eve-of-superintelligence.html)

_2025-01-27 · Ankit Gupta_

These days, I’ve had the privilege of a courtside seat to the radical transformation happening in our society due to artificial intelligence. It has been awe-inspiring and I’m writing this mostly because outside of the Silicon Valley tech bubble it seems as though no one in a position to prepare our society for this is remotely aware of what’s coming. Worse, the trusted arbiters of information in…

## [How unfair is the coin?](https://ankitg.me/blog/2025/01/06/unfair-coins.html)

_2025-01-06 · Ankit Gupta_

I’m reviving my blog after some time away — it’s been an eventful 12 months. In February 2024, Reverie Labs, the startup I co-founded in 2017, was acquired by Ginkgo Bioworks. I’m now on leave from Ginkgo and I’ve joined Y Combinator as a Visiting Partner, giving me the chance to work with the next generation of companies. Especially in this new role, I’ve been thinking a bit about what worked,…

